GHRP-1 - QLT USA

Drug Profile

GHRP-1 - QLT USA

Alternative Names: Growth hormone releasing peptide-1 - Atrix Laboratories

Latest Information Update: 11 Nov 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Tulane University
  • Developer QLT USA
  • Class Oligopeptides
  • Mechanism of Action Growth hormone releasing factor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Cachexia; Nutrition disorders; Short stature

Most Recent Events

  • 01 Oct 2009 QLT USA has been acquired by Tolmar
  • 22 Nov 2004 Atrix Laboratories has been acquired by QLT
  • 24 Jun 2004 Phase-I clinical trials in Cachexia in USA (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top